For pharma & biotech

Your programme should not restart at every decision

ADAPT connects evidence, target reasoning, molecular evaluation, synthesis and assays—preserving the full scientific rationale throughout the programme.

ADAPT global AI workflow
One connected ecosystemEvidence, design, experiments and expert decisions.

Where SoftMining enters

Begin with the scientific question blocking the programme

A collaboration can start from a target, disease area, candidate set, stalled asset or fragmented internal knowledge. The first objective is always a decision—not technology deployment for its own sake.

01 / TARGET

Target and mechanism intelligence

Rank targets using disease context, pathway evidence, mechanistic plausibility and validation strength.

02 / LANDSCAPE

Disease opportunity mapping

Connect literature, patents, omics, clinical evidence and unmet need into a structured opportunity space.

03 / MOLECULES

Candidate evaluation

Prioritise molecules through structural context, physicochemical properties, ADMET and development constraints.

04 / ASSET

Repositioning and failure analysis

Interrogate stalled programmes, alternative mechanisms and the evidence needed to recover asset value.

ADAPT operating model

Every layer contributes to the same programme decision

Literature, targets, molecules, calculations, experiments, pharmacology and expert review are connected layers of one scientific memory.

ONE SCIENTIFIC MEMORYADAPTGlobal AI core
DeepSageEvidence
Target reasoningBiology
Structural models3D context
SIMILISSimilarity
Pareto optimisationTrade-offs
ADMETDevelopability
SYNTHEXSynthesis
AssaysValidation
PharmacologyTranslation
Expert reviewDecisions
FrameUnderstandDesignMake & testLearn
Technical layer: architecture, equations, tool dossiers and scientific references.Explore ADAPT in technical detail →
ADAPT partner workspace connecting evidence, targets, molecules and experimental feedback
A programme workspace, not a sequence of disconnected reportsEvidence, target hypotheses, molecular ranking and experimental feedback are displayed as connected layers of the same programme state.

Evidence and targets

Move from information retrieval to traceable scientific reasoning

ADAPT structures claims, provenance, contradictions and uncertainty, then relates them to the hypotheses and experiments that matter.

01

Map the evidence

claims · sources · confidence

02

Rank mechanisms

context · plausibility · relevance

03

Identify gaps

uncertainty · decisive experiments

04

Preserve rationale

advance · stop · revisit

Multi-objective molecular decisions

The best predicted binder is not necessarily the best candidate

The programme must balance biological activity with properties, safety, synthesis, costs, novelty and evidence quality.

Potency, selectivity & mechanismExposure, clearance & toxicityRoutes, stability & tautomerismPatentability & differentiationCost, time & resourcesExplicit trade-offs

Programme-specific models

Specialised models work as a connected ensemble

Evidence, similarity, structural, optimisation and ADMET capabilities are orchestrated by ADAPT around the programme—not exposed as isolated point tools.

ADAPT orchestration networkAnimated network showing ADAPT coordinating Matisse, Similis, Pareto, Flocking and specialised discovery tools.MATISSESIMILISPARETOFLOCKINGDEEPSAGEADMETSYNTHEXASSAYSPHARMACOLOGYEXPERT REVIEW
ADAPT orchestration networkMatisse · Similis · Pareto · Flocking · specialised tools · one programme-level intelligence

Design–make–test–learn

The computational loop becomes a physical loop

ADAPT interfaces with the SYNTHEX platform. The distinctive feature is not synthesis automation alone, but the connected choice of what to produce and test.

Illustrative automated chemistry laboratory
Illustrative environment. Programme-specific robot configuration and workflows may differ.
01 / ROBOTS

Custom-configured automation

Robotic modules are configured for the chemistry, materials, transfers and analytical interfaces required by the programme.

02 / SUPPORT

Functionalised magnetic nanoparticles

Magnetic solid supports enable parallel handling, separation, washing and multi-step library synthesis.

03 / SELECTION

Model-guided production and testing

ADAPT selects syntheses and assays for information value, then returns success and failure to the next cycle.

DESIGN → MAKE → SEPARATE → TEST → LEARNFaster iteration is a consequence of integration.
Technical layer: miniaturised parallel synthesis, magnetic supports, process-state tracking, QC and ADAPT feedback.Explore SYNTHEX in technical detail →

Illustrative pilot cadence

Move from a bottleneck to a decision-ready programme package

This is an illustrative fast-track cadence. Timing depends on data readiness, chemistry, assay availability and experimental scope.

WEEKS 0–2

Frame

Define the question, available data, success criteria and decision gates.

Programme charter
WEEKS 2–5

Interrogate

Build the evidence landscape, target rationale and uncertainty map.

Evidence package
WEEKS 5–9

Prioritise

Evaluate candidates and expose the important programme trade-offs.

Decision set
WEEKS 9–12+

Close the loop

Define or execute synthesis, assays and the next learning cycle.

Go/no-go package

What remains after the engagement

Deliverables are designed to compound—not expire

The partner receives a decision package and a reusable programme memory that preserves the logic behind the decision.

01

Traceable evidence map

Claims, sources, contradictions, confidence and knowledge gaps.

02

Target or mechanism rationale

Context, assumptions, validation priorities and alternatives.

03

Multi-objective candidate set

Rankings, trade-offs, liabilities, uncertainty and backup options.

04

Synthesis and assay plan

Routes, experiments, decision gates and expected information value.

05

Decision-ready report

Go/no-go rationale, risks, milestones and recommended next action.

06

Reusable ADAPT workspace

Structured programme memory for subsequent discovery cycles.

Ways to work together

Start focused. Expand when the scientific value is visible

Engagements can evolve from one tightly scoped decision to an integrated platform relationship or co-development programme.